← Back to Search

Relief-Hybrid for Chronic Pain

N/A
Waitlist Available
Led By Dimitris Kiosses, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Chronic pain (non-cancer related, most days over the past 3 months)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6, 9, and 12 weeks
Awards & highlights

Study Summary

This trial is meant to study whether the Relief-Hybrid intervention is more effective than Referral to Mental Health/Usual Care in reducing pain severity and pain interference, as well as improving physical functioning, quality of life, and depression symptoms.

Eligible Conditions
  • Chronic Pain
  • Depression

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have experienced non-cancer related chronic pain for most days over the past 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6, 9, and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6, 9, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Mood, as measured by the Daily Photographic Affect Meter (PAM)
Change in Pain-Related Disability, as measured by the Roland-Morris Disability Questionnaire (RMDQ)
Change in depression symptoms, as measured by the Montgomery Asberg Depression Rating Scale (MADRS)
Secondary outcome measures
Activities Monitoring
Affect, as measured by the Positive and Negative Affect Schedule (PANAS).
Interoceptive Awareness, as measured by the Multidimensional Assessment of Interoceptive Awareness (MAIA)
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Relief-HybridExperimental Treatment1 Intervention
Relief-Hybrid relies on a neurobiological model to simplify its behavioral targets and uses mobile technology to augment its interventions. Relief was co-developed with our primary care partners with the goal to be usable by non-physician clinicians of primary care offices eligible to provide billable services.
Group II: Referral to Mental Health/Usual CareActive Control1 Intervention
Continuation of medical attention and treatment provided by physicians and other medical professionals at the primary care practice. Referral for mental health based on clinical indication. Participants receive an educational booklet on pain.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,645 Total Patients Enrolled
16 Trials studying Chronic Pain
2,035 Patients Enrolled for Chronic Pain
National Institute of Mental Health (NIMH)NIH
2,781 Previous Clinical Trials
2,674,978 Total Patients Enrolled
4 Trials studying Chronic Pain
1,352 Patients Enrolled for Chronic Pain
Dimitris Kiosses, PhDPrincipal InvestigatorWeill Medical College of Cornell University
6 Previous Clinical Trials
615 Total Patients Enrolled
2 Trials studying Chronic Pain
230 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary goal of this clinical experiment?

"This clinical trial, which will be assessed over four time points (Baseline, 6 weeks, 9 weeks and 12 weeks), has the primary objective of evaluating Change in Mood using the Daily Photographic Affect Meter (PAM). Secondary objectives include assessing Affect through the Positive and Negative Affect Schedule (PANAS) scores; measuring current Mood by means of a Likert Scale ranging from 0-10; as well as monitoring Activities via a phone application tracking visits to different locations."

Answered by AI

Is enrollment being accepted for this trial at present?

"The research posted on clinicaltrials.gov indicates that this trial is no longer enrolling patients, though it was initially announced on February 1st of 2023 and edited for the final time on September 13th 2022. Fortunately, there are still 1672 medical studies actively seeking participants at this moment in time."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Irving Sherwood Wright Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Behavioral Intervention for Depression and Chronic Pain in Primary Care (Relief-Hybrid)
2023. "A Behavioral Intervention for Depression and Chronic Pain in Primary Care (Relief-Hybrid)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04290845.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top